Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy.

Front Pharmacol · 2024 · PMC11018995 · PMID 38628642

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

approached significanceno p-value reported

Specifically, in the dyslipidemia group, the associations between lipid parameters (TC, TG, HDL-C and LDL-C) and the standard daily dose of VPA, VPA C trough were also investigated, and no results approached significance either ( Supplementary Table S3 ).

also in 8,237 other papers

highly significantno p-value reported

This finding is highly significant for pediatric epilepsy patients undergoing VPA treatment.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.